Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for treating type 2 diabetes in adults. As a dual GIP and GLP-1 receptor agonist, it helps regulate blood sugar whilst supporting weight management. Understanding Mounjaro cost is essential for patients considering this treatment, whether through NHS provision or private prescription. Costs vary significantly depending on access route, dose strength, and provider. This article examines Mounjaro pricing in the UK, compares NHS versus private prescription costs, and explores what patients can expect when accessing Mounjaro through platforms such as Pharmulous, helping you make informed decisions about your diabetes care.

What Is Mounjaro and What Is It Used For?

Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus in adults.^[2][5] It belongs to a class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. By activating both GIP and GLP-1 receptors, Mounjaro helps to regulate blood sugar levels, enhance insulin secretion when glucose is elevated, and reduce glucagon release.

In addition to its glucose-lowering effects, Mounjaro has been shown to support weight loss in many patients. This dual benefit makes it a valuable option for individuals with type 2 diabetes who are also managing obesity or overweight. The Medicines and Healthcare products Regulatory Agency (MHRA) approved Mounjaro for use in the UK, and it is administered as a once-weekly subcutaneous injection using a pre-filled pen device.^[1][2]

Mounjaro is typically prescribed when other diabetes medications, such as metformin, have not achieved adequate glycaemic control. It may be used alone or in combination with other antidiabetic agents, depending on individual patient needs. Treatment usually starts at 2.5 mg once weekly for 4 weeks, then increases gradually as tolerated. Common side effects include nausea, vomiting, diarrhoea, and reduced appetite, which often improve over time.^[1][2]

Important safety information: There is a risk of hypoglycaemia when Mounjaro is used with insulin or sulfonylureas; your prescriber may need to adjust these medications. If you experience severe or persistent abdominal pain, stop taking Mounjaro and seek urgent medical advice as this could indicate pancreatitis. Mounjaro may affect gallbladder function and can cause dehydration due to gastrointestinal effects. Patients with pre-existing diabetic retinopathy, especially those on insulin, may need closer monitoring. Mounjaro is not recommended during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception.^[1][2] If taking oral contraceptives, consider using a barrier method for 4 weeks after starting Mounjaro and after each dose increase.

Mounjaro is not suitable for individuals with type 1 diabetes or diabetic ketoacidosis. If you experience side effects, report them to your healthcare professional and consider reporting via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

How Much Does Mounjaro Cost in the UK?

The cost of Mounjaro in the UK varies depending on whether it is obtained through the NHS or via a private prescription. Mounjaro is available on the NHS for eligible patients with type 2 diabetes, subject to specific clinical criteria outlined by the National Institute for Health and Care Excellence (NICE). However, access may be limited by local formulary decisions and prescribing guidelines.

For private prescriptions, the cost of Mounjaro typically ranges from £150 to £250 per month, depending on the dose strength and the pharmacy or online service dispensing the medication. Mounjaro is available in several dose strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg), with treatment usually starting at the lowest dose and gradually increasing to optimise efficacy and tolerability. Higher doses may incur higher costs.

It is important to note that private pricing can vary significantly between providers and may fluctuate due to national supply constraints affecting GLP-1/GIP medications. Some online pharmacies and telehealth platforms may include additional consultation fees or delivery charges. Patients should always verify that they are purchasing from a registered and regulated pharmacy to ensure the authenticity and safety of the medication.

Key considerations:

• Private prescriptions require an initial consultation with a prescriber (GP or specialist) to assess suitability.

• Ongoing monitoring of blood glucose, weight, and side effects is essential.

• Patients should budget for the cost of regular follow-up consultations in addition to the medication itself.

• For NHS prescriptions in England, patients pay the standard prescription charge (£9.90 per item as of 2024) unless exempt. Those requiring regular prescriptions might benefit from a Prescription Prepayment Certificate (PPC).

If cost is a barrier, discuss alternative treatment options or NHS eligibility with your healthcare professional.

NHS vs Private Prescriptions: Cost Comparison

Understanding the difference between NHS and private prescription costs for Mounjaro is crucial for patients considering this treatment. On the NHS, eligible patients in England pay the standard prescription charge of £9.90 per item (as of 2024), or nothing if they qualify for free prescriptions (e.g., those aged 60 and over, or with a valid exemption certificate). In Scotland, Wales, and Northern Ireland, prescriptions are free for all residents. Patients in England who need multiple prescriptions may benefit from a Prescription Prepayment Certificate (PPC), which costs £31.25 for 3 months or £111.60 for 12 months.

However, NHS access to Mounjaro is not automatic. NICE guidance and local Integrated Care Boards (ICBs) determine eligibility based on factors such as HbA1c levels, body mass index (BMI), previous treatment history, and cardiovascular risk. Patients must meet specific criteria, and in some areas, Mounjaro may only be available through specialist diabetes services rather than primary care.

In contrast, private prescriptions offer greater flexibility but at a significantly higher cost. Patients opting for private treatment can expect to pay £150–£250 per month for the medication itself, plus consultation fees (typically £30–£100 per appointment). Over a year, this can amount to £1,800–£3,000 or more, depending on the dose and provider.

Cost comparison summary:

• NHS: £9.90 per prescription (or free if exempt), but access may be restricted by NICE criteria and local formularies.

• Private: £150–£250/month for medication, plus consultation fees.

It's worth noting that both NHS and private routes may be affected by ongoing national supply constraints for GLP-1/GIP medications. Regardless of the route, prescribing should follow appropriate clinical guidelines. Patients should weigh the financial implications against their eligibility for NHS provision. If you are unsure about your NHS eligibility, request a referral to a diabetes specialist or discuss your options with your GP.

Mounjaro Pricing at Pharmulous: What to Expect

Pharmulous is an online healthcare platform offering private prescriptions for a range of medications, including Mounjaro, for eligible patients in the UK. When considering Mounjaro through Pharmulous, it is important to understand the pricing structure and what is included in the service.

Typically, Pharmulous provides a service that includes an online consultation with a UK-registered prescriber, a private prescription if deemed clinically appropriate, and home delivery of the medication. The cost of Mounjaro at Pharmulous generally falls within the £150–£250 per month range, depending on the prescribed dose. Pricing may vary and is subject to change, particularly given the current supply constraints affecting GLP-1/GIP medications nationally.

What to expect when using Pharmulous:

• Initial consultation: Complete an online health questionnaire reviewed by a qualified prescriber. This ensures Mounjaro is safe and appropriate for you based on NICE and clinical guidelines.

• Prescription issuance: If approved, a private prescription is issued and sent to a registered pharmacy.

• Medication delivery: Mounjaro is dispatched directly to your home, usually within a few working days, subject to availability.

• Follow-up care: Ongoing monitoring and repeat prescriptions are typically available through the platform.

Patients should verify that any online provider is registered with the General Pharmaceutical Council (GPhC), that prescribers are registered with the General Medical Council (GMC), and where applicable, that the service is registered with the Care Quality Commission (CQC). This ensures compliance with UK regulations and patient safety standards.

Important reminders:

• Always disclose your full medical history, including current medications and allergies.

• Report any side effects to your healthcare professional promptly and consider using the MHRA Yellow Card scheme.

• Do not share your medication with others, even if they have similar symptoms.

• The same clinical eligibility criteria apply to both NHS and private prescriptions.

If you experience financial difficulty affording Mounjaro privately, discuss NHS eligibility or alternative diabetes treatments with your GP. Your healthcare professional can help you find the most appropriate and cost-effective solution for managing your condition.

Frequently Asked Questions